Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 03, 2015	Sep. 27, 2014
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (8,542)	$ (45,384)
Investing Activities
Capital expenditures	(14,628)	(8,472)
Proceeds from sale of assets	140	9
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	(14,488)	(8,463)
Financing Activities
Borrowings under ABL facilities	135,731	161,931
Payments under ABL facilities	(110,653)	(116,017)
Borrowings from affiliates	0	0
Repayments to affiliates	0	0
Net cash provided by (used in) financing activities	25,078	45,914
Effect of exchange rate changes on cash and cash equivalents	(70)	(471)
Net increase (decrease) in cash and cash equivalents	1,978	(8,404)
Cash and cash equivalents at beginning of period	5,963	20,815
Cash and cash equivalents at end of period	7,941	12,411
Company
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(31,035)	(54,847)
Investing Activities
Capital expenditures	(13,160)	(7,187)
Proceeds from sale of assets	138	6
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	2,000	3,900
Net cash (used in) provided by investing activities	(11,022)	(3,281)
Financing Activities
Borrowings under ABL facilities	71,700	113,700
Payments under ABL facilities	(54,700)	(67,700)
Borrowings from affiliates	40,418	12,696
Repayments to affiliates	(14,000)	0
Net cash provided by (used in) financing activities	43,418	58,696
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	1,361	568
Cash and cash equivalents at beginning of period	5,933	7,566
Cash and cash equivalents at end of period	7,294	8,134
Co-Issuer
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	0	0
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Borrowings from affiliates	0	0
Repayments to affiliates	0	0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	15,531	12,948
Investing Activities
Capital expenditures	(113)	(252)
Proceeds from sale of assets	0	0
Payments on loans to affiliates	(15,418)	(12,696)
Receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	(15,531)	(12,948)
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Borrowings from affiliates	0	0
Repayments to affiliates	0	0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	6,962	(3,485)
Investing Activities
Capital expenditures	(1,355)	(1,033)
Proceeds from sale of assets	2	3
Payments on loans to affiliates	(25,000)	0
Receipts on loans to affiliates	14,000	0
Net cash (used in) provided by investing activities	(12,353)	(1,030)
Financing Activities
Borrowings under ABL facilities	64,031	48,231
Payments under ABL facilities	(55,953)	(48,317)
Borrowings from affiliates	0	0
Repayments to affiliates	(2,000)	(3,900)
Net cash provided by (used in) financing activities	6,078	(3,986)
Effect of exchange rate changes on cash and cash equivalents	(70)	(471)
Net increase (decrease) in cash and cash equivalents	617	(8,972)
Cash and cash equivalents at beginning of period	30	13,249
Cash and cash equivalents at end of period	647	4,277
Reclassification/Eliminations
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Proceeds from sale of assets	0	0
Payments on loans to affiliates	40,418	12,696
Receipts on loans to affiliates	(16,000)	(3,900)
Net cash (used in) provided by investing activities	24,418	8,796
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Borrowings from affiliates	(40,418)	(12,696)
Repayments to affiliates	16,000	3,900
Net cash provided by (used in) financing activities	(24,418)	(8,796)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0